Savara (SVRA) Depreciation and Depletion (2016 - 2018)
Savara (SVRA) reported Depreciation and Depletion of $139000.0 for Q4 2018, up 52.75% year-over-year from $91000.0 in Q4 2017, and up 9.45% quarter-over-quarter from $127000.0 in Q3 2018.
Savara (SVRA) Depreciation and Depletion (2016 - 2018) Analysis & Trends
Savara (SVRA) has 3 years of Depreciation and Depletion data on file, last reported at $139000.0 in Q4 2018.
- Depreciation and Depletion for Q4 2018 came in at $139000.0, up 52.75% year-over-year; the trailing twelve-month figure through Dec 2018 was $526000.0 (up 44.9% YoY), and the FY2021 annual result was $100000.0, down 66.67% from the prior year.
- Depreciation and Depletion improved to $139000.0 in Q4 2018 per SVRA's latest filing, from $127000.0 in the prior quarter.
- Over five years, Depreciation and Depletion peaked at $153000.0 in Q2 2018 and troughed at $85000.0 in Q2 2016.
- A 3-year average of $104545.5 and a median of $91000.0 in 2017 frame the typical range for Depreciation and Depletion.
- The sharpest annual moves came in 2017 and 2018: Depreciation and Depletion climbed 1.11% in 2017, then soared 68.13% in 2018.
- A 3-year view of Depreciation and Depletion shows it stood at $90000.0 in 2016, then grew by 1.11% to $91000.0 in 2017, then surged by 52.75% to $139000.0 in 2018.
- Business Quant data shows SVRA's Depreciation and Depletion at $139000.0 in Q4 2018, $127000.0 in Q3 2018, and $153000.0 in Q2 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1,395.22 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Savara | 1.39 Bn | 1.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 139,000.00 |
| Dec 31, 2018 | 139,000.00 |
| Sep 30, 2018 | 127,000.00 |
| Sep 30, 2018 | 127,000.00 |
| Jun 30, 2018 | 153,000.00 |
| Jun 30, 2018 | 153,000.00 |
| Mar 31, 2018 | 107,000.00 |
| Mar 31, 2018 | 107,000.00 |
| Dec 31, 2017 | 91,000.00 |
| Dec 31, 2017 | 91,000.00 |
| Sep 30, 2017 | 91,000.00 |
| Sep 30, 2017 | 91,000.00 |
| Jun 30, 2017 | 91,000.00 |
| Jun 30, 2017 | 91,000.00 |
| Mar 31, 2017 | 90,000.00 |
| Mar 31, 2017 | 90,000.00 |
| Dec 31, 2016 | 90,000.00 |
| Dec 31, 2016 | 90,000.00 |
| Sep 30, 2016 | 86,000.00 |
| Sep 30, 2016 | 86,000.00 |